| Serial Number | 88682860 |
| Word Mark | MONJUVI |
| Filing Date | Wednesday, November 6, 2019 |
| Status | 705 - PARTIAL SECTION 8 & 15 ACCEPTED AND ACKNOWLEDGED |
| Status Date | Thursday, July 16, 2026 |
| Registration Number | 6173000 |
| Registration Date | Tuesday, October 13, 2020 |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, July 28, 2020 |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Description of Mark | The mark consists of the term "MONJUVI" having a spherical shape appearing above the "i". |
| Goods and Services | [Research and development in the pharmaceutical and biotechnology fields; research and development of vaccines and medicines; scientific and technological services and research and design services, namely, scientific research, analysis, and testing services in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; biological research and medical research; chemical and biochemical analysis services; laboratory research in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; clinical research in connection with the treatment and prevention of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; conducting clinical trials for others; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development services in the field of antibodies] |
| Goods and Services | Pharmaceuticals and pharmaceutical preparations for human[ and veterinary] use for the treatment and prevention of metabolic disorders, cancer, inflammatory diseases, [ and restenosis; vaccine preparations; vaccines;] biological preparations in the nature of antibodies for use in the treatment of metabolic disorders, cancer, inflammatory diseases, [ and restenosis; antibodies sold as a component ingredient of pharmaceuticals for the treatment of metabolic disorders, cancer, inflammatory diseases, and restenosis; antibodies for use in the manufacture of active ingredients of pharmaceuticals and vaccines for use in the treatment and prevention of metabolic disorders, cancer, inflammatory diseases, and restenosis; diagnostic preparations for medical or veterinary purposes; biological preparations for human medical diagnostics and analysis for the treatment of metabolic disorders, cancer, inflammatory diseases, and restenosis; sanitary preparations for medical use; medical diagnostic reagents; clinical medical reagents;] biological preparations for medical [and veterinary] purposes for use in the treatment of metabolic disorders, cancer, inflammatory diseases [, and restenosis; none of the foregoing goods for use in connection with the treatment or prevention of ear disorders] |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, November 14, 2019 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | B - Sec. 8 - Class(es) in a Multiple Class registration |
| Class Status Date | Thursday, July 16, 2026 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | INCYTE HOLDINGS CORPORATION |
| Party Type | 31 - New Owner After Registration |
| Legal Entity Type | 03 - Corporation |
| Address | WILMINGTON, DE 19803 US |
| Party Name | MorphoSys AG |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | Planegg D-82152 DE |
| Party Name | MorphoSys AG |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Planegg D-82152 DE |
| Party Name | MorphoSys AG |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Planegg D-82152 DE |
| Event Date | Event Description |
| Saturday, November 9, 2019 | NEW APPLICATION ENTERED |
| Thursday, November 14, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, November 15, 2019 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Sunday, December 15, 2019 | ASSIGNED TO EXAMINER |
| Wednesday, December 18, 2019 | NON-FINAL ACTION WRITTEN |
| Wednesday, December 18, 2019 | NON-FINAL ACTION E-MAILED |
| Wednesday, December 18, 2019 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, June 10, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, June 18, 2020 | ASSIGNED TO LIE |
| Monday, June 22, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, June 22, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, June 22, 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, July 8, 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, July 28, 2020 | PUBLISHED FOR OPPOSITION |
| Tuesday, July 28, 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, October 13, 2020 | REGISTERED-PRINCIPAL REGISTER |
| Wednesday, April 24, 2024 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| Wednesday, May 1, 2024 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Monday, June 17, 2024 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Monday, June 17, 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Monday, June 17, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Monday, June 17, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Monday, June 17, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, October 13, 2025 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Friday, April 10, 2026 | TEAS SECTION 8 & 15 RECEIVED |
| Monday, July 13, 2026 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Thursday, July 16, 2026 | REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
| Thursday, July 16, 2026 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED |